4 ms·
I've seen this said a bunch of times but never anything to actually back it up. The fact that big pharma companies tend to have fantastic margins and spend simi
by Chestofdraw 10y ago
I've seen this said a bunch of times but never anything to actually back it up.
The fact that big pharma companies tend to have fantastic margins and spend similar amounts on R&D as they do on marketing makes me think that it's probably bollocks.
The idea that big pharma companies are happily scalping Americans just so they can provide drugs to countries that can't actually afford them is just... absurd.
- bjterry 10y agoHere is a recent blog post that has some references to economics research papers around this general topic, but likely not directly addressing your exact claim. Nonetheless, you may find it interesting: http://slatestarcodex.com/2016/09/07/reverse-voxsplaining-brand-name-drugs/ http://slatestarcodex.com/2016/09/07/reverse-voxsplaining-br...
- cmdrfred 10y agoGrandparent is correct. For GSK: R&D was 15% of their budget, while 'selling, general and administration' was 39%.[1] [1]http://www.bizjournals.com/triangle/news/2016/07/19/where-gsk-ranks-in-r-d-spending-against-sales-and.html http://www.bizjournals.com/triangle/news/2016/07/19/where-gs...